<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01008384</url>
  </required_header>
  <id_info>
    <org_study_id>MAP-0683</org_study_id>
    <nct_id>NCT01008384</nct_id>
  </id_info>
  <brief_title>The Effect of Vitamin D Repletion on Small Low Density Lipoprotein (LDL) Particle Number in Subjects at Elevated Cardiovascular Risk</brief_title>
  <official_title>The Effect of Vitamin D Repletion on Small LDL Particle Number in Subjects at Elevated Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, added to
      others, and available as a dietary supplement. It is also produced in the body when
      ultraviolet rays from sunlight strike the skin and trigger vitamin D synthesis. Vitamin D is
      essential for promoting calcium absorption and maintaining adequate serum calcium and
      phosphate concentrations to enable normal mineralization of bone and bone growth. Without
      sufficient vitamin D, bones can become thin, brittle, or misshapen. Vitamin D sufficiency
      prevents rickets in children and osteomalacia in adults. Together with calcium, vitamin D
      also helps protect older adults from osteoporosis. Many people have low levels of Vitamin D.
      Replacing Vitamin D is thought to help lower the risk of heart disease. Vitamin D may be
      helpful, but it could also be harmful. The investigators are studying the effect of Vitamin D
      on the level of a harmful kind of cholesterol. Participants will have their cholesterol
      levels measured and then receive either Vitamin D or a placebo. After 2 months of treatment,
      the investigators will measure their cholesterol levels again.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Small LDL particle concentration</measure>
    <time_frame>Visit 5</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 given for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>50,000 units taken orally once a week for 8 weeks</description>
    <arm_group_label>Vitamin D3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years and &lt; 85 years

          2. Vitamin D 25-OH level &lt;20 ng/ml

          3. One of the following risk factors:

               -  Known coronary artery disease (CAD) or a CAD equivalent (e.g. diabetes, chronic
                  kidney disease, etc)

               -  BMI &gt; 30 kg/m2

               -  Random Glucose Level &gt; 200mg/dl

               -  Increased Waist Circumference (male: &gt; 40in; Females: &gt; 35in.)

               -  Decreased HDL (Male: &lt; 40mg/dl; Female: &lt; 50mf/dl)

               -  Framingham Risk Score &gt; 10%

               -  hsCRP &gt; 2 mg/L

        Exclusion Criteria:

          1. Serum phosphorus level &gt; 5.5 mg/dl

          2. Estimated GFR &lt;30 ml/min/1.73m2

          3. Use of Vitamin D &gt;400 IU/day within 1 month of most recent Vitamin D 25-OH
             determination

          4. Use of calcitriol or other &quot;activated&quot; vitamin D

          5. Change in statin, ezetimibe, niacin, fibrate dose within 1 month

          6. Concurrent participation in an investigational drug study

          7. Have any other condition, which in the opinion of the investigator, should prohibit
             the participation in the study

          8. Serum calcium level &gt;10.5 mg/dl

          9. anti-epileptic medication

         10. triglycerides &gt; 400 mg/dL

         11. BMI &gt; 40 kg/m2

         12. Evidence of cirrhosis as evidenced by AST &gt; 3 x upper limit, ALT &gt; 3 x upper limit,
             bilirubin &gt; 1.5 mg/dL , albumin &lt; 3.0 g/dL, PT &gt; 14.5 sec

         13. Pregnant or Lactating Females
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manish Ponda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Rockefeller University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Rockefeller University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2009</study_first_submitted>
  <study_first_submitted_qc>November 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2009</study_first_posted>
  <last_update_submitted>May 31, 2012</last_update_submitted>
  <last_update_submitted_qc>May 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

